Cointime

  • News
  • Insight
  • Currencies
  • Columns
  • Events
  • Bitcoin $114,522.10 -0.76%
  • Ethereum $4,113.83 -1.31%
  • BNB $1,135.32 -1.36%
  • Optimism $0.45 -1.44%
  • Arbitrum $0.33 -2.67%
  • Solana $200.15 +0.01%
  • Polygon $0.22 +2.77%
  • Cosmos $3.17 -1.57%
  • Avalanche $20.23 -1.66%
  • Bitcoin $114,522.10 -0.76%
  • Ethereum $4,113.83 -1.31%
  • BNB $1,135.32 -1.36%
  • Optimism $0.45 -1.44%
  • Arbitrum $0.33 -2.67%
  • Solana $200.15 +0.01%
  • Polygon $0.22 +2.77%
  • Cosmos $3.17 -1.57%
  • Avalanche $20.23 -1.66%
Home / Nimbus Therapeutics / investors

Nimbus Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
7
17
Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.
Investor Name Lead Investor Funding Round
Access Biotechnology - Series Unknown
Atlas Venture - Series Unknown
Bain Capital Life Sciences - Series Unknown
Bill Gates - Series Unknown
Biotechnology Value Fund - Series Unknown
Lightstone Ventures - Series Unknown
Pfizer Venture Investments - Series Unknown
RA Capital Management - Series Unknown
SR One - Series Unknown
SV Health Investors - Series Unknown
Commodore Capital - Series Unknown
Logos Capital - Series Unknown
Surveyor Capital - Series Unknown
BVF Partners - Series Unknown
Lilly Ventures - Series C
Schrödinger - Series C
Richard Friesner - Seed

Contact

Cambridge,Massachusetts,United States
(857) 999-2009
Cointime
Insight
  • Latest News
  • Web3
  • Blockchain
  • Metaverse
  • Bitcoin
  • Ethereum
  • NFT
  • DeFi
Features
  • Startups
  • Research
  • Technology
  • Topics
  • Columns
  • Currencies
  • Events
  • Tags
RSS
  • Latest News
  • Startups
  • Research
  • Technology
Company
  • About
  • Advertise
  • Disclaimers
  • © 2023 Cointime. All rights reserved.
  • Privacy Policy
  • Terms & Conditions